IMRX vs UHS · $124.2M cap vs P/E 5.9, rev $9.13B
Immuneering Corp (IMRX) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
IMRX does not have a complete income-statement cache yet.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
IMRX currently screens at market cap $124.2M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the IMRX and UHS stock pages for the full models.
Not investment advice.